IGI Logo

Below on the  Budget Reactions 2024 by Dr. K. Anand Kumar, MD, Indian Immunologicals  

“I commend the initiatives outlined in the Interim Budget 2024, particularly those addressing women and children's health. These measures signify a concerted effort to strengthen India's healthcare system by prioritizing preventive care, expanding access to essential services, and leveraging innovation for better health outcomes.

The decision to provide and actively encourage cervical cancer vaccines for 9–14-year-olds reflects a proactive approach to preventing a significant health burden among young girls. Cervical cancer is the fourth most common cancer in women globally, with millions of cases reported annually. Investing in this preventive measure is poised to reduce the incidence of cervical cancer and its associated morbidity and mortality rates in the future.

The budget has also allocated INR 1 lakh crore towards establishing a corpus, offering a 50-year interest-free loan to scale up research and innovation significantly in sunrise industries. This allocation presents a promising advancement within the vaccine industry. It allows for the integration of new-age technologies in vaccine development processes, especially for mRNA and Adenoviral vector vaccines.”

Above views are of the author and not of the website kindly read disclaimer